BWS Financial Upgrades SciClone Pharmaceuticals (SCLN) to Buy 8:17 am ET 04/09/2010- StreetInsider BWS Financial upgrades Sciclone Pharmaceuticals (Nasdaq: SCLN) from Hold to Buy with a new $7.25 price target.
The firm said, ..."to aid the growth of ZADAXIN, has been steadily adding to its sales force in China. It is becoming apparent that the Company has been gaining good traction with their product in China."
not familiar w/ BWS here but SCLN could get interesting w/ first speedbump @ $4.25
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.